QDII Fund NAV and reports

  

UBS QDII – Overseas Funds NameCurrencyISIN Product Registration Code (Foreign Currency) Product Registration Code (CNY) Net Asset Value 
(NAV)
Accumuldated Net Asset Value Date of NAV Regular reports

UBS (Lux) Strategy Fund - Balanced (USD) P-acc

USD

LU0049785792

C1074216C000015 

C1074216C000020

4832.18

4832.18

07.10.2026

(PDF, 301 KB)

UBS (Lux) Strategy Xtra SICAV - Balanced (USD) P-acc

USD

LU0200191152

C1074219C000027

C1074216C000030

23.64

23.64

07.10.2026

(PDF, 285 KB)

UBS (Lux) Equity Fund - China Opportunity (USD) P-acc

USD

LU0067412154

C1074218C000014

C1074218C000066

1195.56

1195.56

08.10.2026

(PDF, 448 KB)

UBS (Lux) Equity Fund – Sustainable Health Transformation (USD) P-acc

USD

LU0085953304

C1074216C000045

C1074216C000036

526.37

526.37

07.10.2026

(PDF, 302 KB)

UBS (Lux) Bond Fund – Asia Flexible (USD) P-acc

USD

LU0464244333

C1074219C000029

C1074216C000031

155.73

155.73

07.10.2026

(PDF, 288 KB)

Capital Group New Perspective (LUX) Z

USD

LU1295555210

C1074219000001

C1074219000002

33.5286

33.5286

07.10.2026

(PDF, 355 KB)

UBS (Lux) Equity SICAV - All China (USD) P-acc

USD

LU1807302812

C1074221000001

C1074221000002

82.65

82.65

08.10.2026

(PDF, 486 KB)

BGF Next Generation Technology A2 USD

USD

LU1861215975

C1074221000003

C1074221000004

36.89

36.89

08.10.2026

(PDF, 384 KB)

BGF World Healthscience A2 USD

USD

LU0122379950

C1074221000005

C1074221000006

77.33

77.33

08.10.2026

(PDF, 439 KB)

UBS Balanced Investing USD P-acc

USD

LU1852198289

C1074221000007

C1074221000008

158.1

158.1

07.10.2026

(PDF, 326 KB)

BGF Systematic Glb Eq High Income A2 USD

USD

LU0265550359

C1074222000001

C1074222000002

28.04

28.04

08.10.2026

(PDF, 502 KB)

UBS (Lux) Equity SICAV - Long Term Theme (USD) P-acc

USD

LU1323610961

C1074222000003

C1074222000004

301.56

301.56

07.10.2026

(PDF, 417 KB)

UBS (Lux) Bond SICAV - USD Corporates (USD) P-acc

USD

LU0172069584

C1074225000002

C1074225000003

20.49

20.49

07.10.2026

(PDF, 425 KB)

UBS (Lux) Bond SICAV - Short Term USD Corporates (USD) P-acc

USD

LU0151774972

C1074225000004

C1074225000001

166.42

166.42

07.10.2026

(PDF, 290 KB)

BGF Continental Eurp Flex A2 USD Hdg

USD

LU1196525536

C1074225000006

C1074225000008

30.76

30.76

08.10.2026

(PDF, 374 KB)

BGF Continental Eurp Flex A2 EUR

EUR

LU0224105477

C1074225000005

C1074225000007

50.97

50.97

08.10.2026

(PDF, 377 KB)

UBS (Irl) Select MMF – USD

USD

IE00BWWCPZ76

C1074225000009

C1074225000010

124.838

124.838

07.10.2026

(PDF, 424 KB)

Declaration:

The above NAV information for an Overseas Fund only represents the performance of that fund on the above given date (or up to the above given date), and are for reference purposes only. The value that an investor may receive upon redemption of a UBS QDII Overseas Fund is not equal to the relevant NAV of that fund. The redemption value could be affected by the fees and levies applicable to the relevant Overseas Fund. One shall refer to the redemption confirmation for the specific redemption amount.

All of the above NAV information comes from the respective overseas fund managers. The Bank makes no representations or warranties, whether explicit or implied, and assumes no responsibilities in respect of the correctness and completeness of the information herein. 

The information mentioned herein does not constitute and is not intended to be construed as a solicitation, recommendation, an invitation for offer or an offer to sell any products and services. The QDII Product is different from deposits and will involve certain risks, and the investor shall make investment decisions prudently. Before any investment decision is made, the investor shall carefully consider the suitability of the product and service. In addition, past performance is not an indicator of future performance.

Prospective investors are advised to carefully read the formal transaction documentation associated with the QDII product to understand product details and risks.

The update and disclosure of the relevant information are subject to the provision of information by, and the disclosure timelineing of, the issuer or manager of the Overseas Fund. Accordingly, there may be circumstances where the quarterly report is not disclosed within fifteen Business Days after the end of each quarter, or where the relevant reports or information are not disclosed within other expected timelines. The Bank will disclose such information to the Client within a reasonably practicable period after receiving the relevant Overseas Fund information.